
Podcast #72 · 14 Jul 2026
Optimizing Liver-Directed Interventions for Neuroendocrine Tumors
- Nuclear Medicine
- Peptide Receptor Radionuclide Therapy (PRRT)
- Medical Oncology
- Liver Metastasis
- Transarterial Chemoembolization (TACE)
- Neuroendocrine Tumor (NET)
- Interventional Radiology (IR)
- Y90 Radioembolization
- Histotripsy
What factors come into play when deciding whether to use liver-directed therapy or systemic therapies for neuroendocrine tumors? In this episode of the BackTable Tumor Board Podcast, Dr. Lingling Du, Dr. Chih-Yi Liao, and Dr. Abdul Khan discuss the structure of a multidisciplinary tumor board and how they approach decision-making for patients with neuroendocrine tumors. The conversation explores who benefits most from liver-directed therapy, optimal timing for intervention, and the importance of individualized treatment planning.

